Jérôme Marzinski becomes CEO at OxSonics Therapeutics

Saturday 19 November 2022
OxSonics Therapeutics Ltd
Appointee name
Jérôme Marzinski

United Kingdom

Jérôme Marzinski, a seasoned medical technology leader, has been appointed chief executive of OxSonics Therapeutics Ltd, a UK company developing drug delivery technology using ultrasound. Mr Marzinski is an independent board member of Cimon Medical AS, a Norwegian ultrasound specialist, where he was also interim CEO. Prior to this, he was chief executive at Visiometrics SL, an ophthalmic diagnostic company, now part of Halma Plc.

Mr Marzinski holds a degree in corporate finance and accounting from the University of Lille, France.

OxSonics announced the appointment on 7 November 2022.

Copyright 2022 Evernow Publishing Ltd